Passage Bio, Inc.

PASG · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$52,773$57,626$63,357$37,573
Short-Term Investments$0$0$0$39,183
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$2,957$2,689$2,121$838
Total Curr. Assets$55,730$60,315$66,669$78,815
Property Plant & Equip (Net)$18,160$18,613$19,063$23,134
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$270$270$274$463
Total NC Assets$18,430$18,883$19,337$23,597
Other Assets$0$0$0$0
Total Assets$74,160$79,198$86,006$102,412
Liabilities
Payables$952$2,395$1,458$742
Short-Term Debt$3,542$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$17,751$11,320$10,300$12,631
Total Curr. Liab.$22,245$19,801$17,825$19,363
LT Debt$20,795$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$20,795$21,139$21,475$21,788
Other Liabilities$0$0$0$0
Cap. Leases$24,337$24,731$25,116$25,476
Total Liabilities$43,040$40,940$39,300$41,151
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$6$6
Retained Earnings-$691,774-$684,025-$674,640-$659,235
AOCI$0$0$0$8
Other Equity$722,894$0$0$0
Total Equity$31,120$38,258$46,706$61,261
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$74,160$79,198$86,006$102,412
Net Debt-$28,436-$57,626-$63,357-$37,573